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on hemorrhage location. Logistic regression using dichotomized outcome scales was applied to determine predictors of poor outcome.
Results
Among 375 cases of supratentorial ICH with volumes <30 mL, expansion and END rates were 19.2% and 7.5%, respectively. Hemorrhage growth was independently associated with END (odds ratio: 28.7, 95% confidence interval [CI]: 8.51-96.5; p<0.0001). Expansion rates did not differ according to ICH location. Overall, 13.9% (exact binomial 95% CI: 10.5-17.8) died in the hospital and 29.1% (CI: 24.5-34.0) had severe disability at 30 days; a cumulative poor outcome rate of 42.9% (CI: 37.9-48.1). Age, admission Glasgow Coma Scale, intraventricular extension, and END were independently associated with poor outcome. There was no difference in poor outcome rates between lobar and deep locations (40.2% versus 43.8%, p=0.56).
Conclusion
Patients with supratentorial ICH <30 mL have high rates of poor outcome at 30 days, regardless of location. Nearly one in five hematomas <30 mL expands, leading to END or death.
INTRODUCTION
Intracerebral hemorrhage (ICH) is the most pernicious form of stroke, wherein approximately 1/3 of patients die within the first 30 days [1] . Several characteristics independently predict early death and poor functional outcome in ICH patients [2, 3] . Initial ICH volume and hematoma enlargement are among the strongest determinants of mortality and disability [4, 5] . As such, Page 3 of 21 attenuation of hematoma expansion has been the objective of many interventional clinical trials in ICH and remains a tantalizing therapeutic target. It is unclear, however, whether this strategy has a beneficial effect on outcomes notwithstanding ICH size. Very large hemorrhages inherently have less favorable outcomes. The rates of mortality and poor outcome especially increase when ICH volume exceeds 30 mL [2] [3] [4] . This cut-off is used as a prognostic item in estimation of the ICH Score [2, 3] . Although outcomes in patients with the initial ICH volume ≥30 mL have been adequately delineated in various studies, less is known about supratentorial ICH <30 mL. The aim of this study was to determine the characteristics, clinical course, and outcomes of patients with small (<30 mL) supratentorial hematomas.
METHODS

Study Design
A cohort design was applied, wherein ICH occurrence defined the qualifying event. We used the
Multi-National survey of Epidemiology, Morbidity, and Outcomes iN Intra-Cerebral
Haemorrhage (MNEMONICH) registry to compile the data for this study. MNEMONICH (NCT2567162 ClinicalTrials.gov) is an ongoing, international, multicenter, observational, collaborative database of consecutive adult (≥18 years of age) patients with spontaneous ICH from participating centers in Europe, Latin America, and the United States [6, 7] . It consists of existing and ongoing datasets from international collaborators who have agreed to a mutual peerto-peer exchange of collected data on spontaneous ICH patients aged 
Case Ascertainment
We specifically extracted data on patients who presented with supratentorial ICH <30 mL in volume. Patients with anticoagulant-associated ICH are also included. To prevent any potential confounding effects, patients who had undergone surgical evacuation were excluded.
Neuroimaging
In MNEMONICH, spontaneous ICH is defined as acute intraparenchymal bleeding confirmed by CT scan, in the absence of secondary etiology (e.g. brain tumors/infections, vascular malformations, aneurysms, hemorrhagic transformation of cerebral infarcts, and trauma). ICH volume was calculated using the ABC/2 method [8] . No data on CT angiography or specifically the "spot sign" were collected.
Outcome Determination
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We gathered data on early neurological deterioration (END) and ICH expansion. END was defined as ≥3 points decrease in the GCS score for non-comatose patients (GCS >8) or ≥2 point decrease for comatose patients (GCS ≤8), presence of a new neurological deficit or worsening of previous deficit, or the appearance of clinical signs of brain herniation within 24 hours of admission [9] . ICH expansion was defined as any increase in the original hematoma volume by 33% or more.
Statistical Methods
We divided ICH cases into 3 categories based on location: thalamus, basal ganglia/internal capsule (including the caudate nucleus), and lobar. Data were presented as mean ± standard deviation for normally distributed continuous variables, median and interquartile range for nonnormally distributed continuous variables, and as frequencies for categorical variables. Baseline characteristics between patient groups were compared using χ 2 -test, ANOVA, and KruskalWallis test, as appropriate. Multiple comparisons were conducted using Marascuillo's post hoc procedure for proportions, ANOVA with Bonferroni corrections for normally distributed variables, and Kruskal-Wallis test with Dunn-Bonferroni post hoc method for non-normally distributed variables. We further divided the cases into volume tertiles, <10 mL, 10-20 mL, and >20 mL, and used with Marascuillo's post hoc analysis following comparing multiple proportions to compare hematoma expansion rates of each volume tertile according to location.
The primary outcomes was the composite endpoint of severe disability (defined as GOS ≤3) and 30-day mortality. To determine whether ICH location or other known ICH prognostic factors were associated with the primary outcome, multivariable logistic regression was performed. In this model, we adjusted for prespecified baseline characteristics known potentially to influence survival and outcomes in ICH: gender, IVH, END, INR >1.4 on admission were included as binary variables; age, baseline ICH volume (log transformed), serum glucose at admission, and GCS score were treated as continuous variables. Goodness of the model for assessment of multivariate collinearity was tested using the variance inflation factor with exclusion in the final model of collinear variables. We reported the results as unadjusted and adjusted odds ratios (OR) with 95% confidence intervals (CI). Statistical significance for all analyses was set at p<0.05. Statistical analyses were performed using SPSS® 22.0 (IBM® Inc.).
RESULTS
Baseline Characteristics
Among 716 ICH patients included in the registry, there were 375 (52.4%) cases of supratentorial ICH with volumes <30 mL. The mean age for this group was 67.1 ±12.3 years and 63.7% were men. Table 1 compares the baseline characteristics of the study cohort according to specific hematoma location (Supplementary Table I with thalamic ICH and highest in the lobar group. Thalamic ICH patients also presented with higher median GCS score than the rest of the cohort (basal ganglia/internal capsule patients had the lowest). Lobar ICH patients were more likely to be on oral anticoagulants than the remainder of the cohort, but the proportion of patients with INR >1.4 in each group was not different.
Clinical Course
Hematoma expansion and END rates for the total cohort were 19.2% (9.2% had missing data) and 7.5%, respectively. The rates and measure of expansion and END did not differ between the three locations ( (Table 3) . However, in the lobar and basal ganglia/internal capsule groups, ICH volume categories 1-9 mL showed significantly higher rates of expansion than volumes >9 mL (Table 3) . No significant difference between volume tertiles was noted in the rates of thalamic hematoma expansion.
Outcomes
Fifty-two patients (13.9%) died in the hospital, and 109 (29.1%) had a severe disability (GOS scores, 3 and 2) at 30 days. The overall rate of poor outcome (GOS ≤3) was 42.9%. We found no difference between the three ICH location in the rates of in-hospital death, severe disability at 30 days, or poor outcome ( (Table 4) .
DISCUSSION
This study demonstrated that supratentorial hematomas that are <30 mL in volume comprise a large proportion of patients with ICH. Within this category, 42.9% died in the hospital or were left with severe disability at 30 days. Although this figure may be lower than the overall estimated rate of poor outcome for ICH, it highlights the fact that even smaller-volume supratentorial hematomas can expand and have devastating outcomes. A recent study looking at 315 ICH patients stratified by ICH volume showed that the rates of >33% expansion in volume categories of 3-10 mL and 10-20 mL were 26% and 32.9%, respectively [10] . At 90 days, in patients with ICH volumes 3-20 mL, the rate of poor outcome (modified Rankin Scale score ≥4) was 41.9%, which is very close to our number. In our study, expansion was independently associated with END and ultimately, poor outcome. Moreover, we found that known determinants of mortality and poor outcome (age, initial GCS score, ICH volume, and IVH) appropriately apply to this subset of ICH patients [2, 3] .
One of the earliest studies looking at the significance of ICH volume in predicting outcomes
showed that the overall 30-day mortality rates for ICH volumes <30 mL was 23% for deep and 7% for lobar hemorrhages [4] . A combination of hematoma volume and the initial GCS score was a strong predictor of 30-day morbidity and mortality. The probabilities of death by 30 days with ICH volume <30 mL and initial GCS score ≥9 and ≤8 were 19% and 44%, respectively [4] .
Our study, too, showed that GCS score on presentation was a strong predictor of outcome. While prior studies have shown initial ICH volume as an independent determinant of GCS score on presentation, we found low GCS to be a powerful predictor of poor outcome even in patients with smaller-volume hematomas [11] .
Another important finding in our study was that in hematomas <30 mL, specific ICH locations
were not major determinants of mortality or outcome. Lobar hemorrhages were, on average, larger in volume in our study, which is consistent with prior reports [12] . However, the prognostication capacity of deep localisation may be volume-dependent, consummating at volumes above 30 mL, where deep hematomas have worse outcomes than lobar hemorrhages but not for volumes below 30 mL [13] . In addition, the mortality rate in patients with thalamic hemorrhages was similar to that of patient with basal ganglia/internal capsule hematomas, contrary to previous investigations, suggesting that the prognostication capacity of different deep localisation is prevalently volume-dependent [14] [15] [16] .
Surgical evacuation of deeply situated hematomas with volumes <30 mL, even with minimally invasive techniques, does not seem to carry a substantial benefit, regardless of the initial GCS score [17, 18] . In a study of 400 patients with spontaneous putaminal and thalamic hemorrhages who underwent conservative treatment versus surgical evacuation (including endoscopic and stereotactic aspiration), mortality rates were lower for the conservative management group, compared with surgical treatment when the GCS score was 3 to 12 and ICH volume <30 mL [18] . Currently, minimally invasive hematoma evacuation strategies under investigation only include patients with ICH volume ≥30 mL, consequently leaving a treatment gap for hematomas with smaller volume [19] . This subgroup of ICH patients may therefore, be suitable candidates for hemostatic therapy, which requires examination in a randomized trial.
Our study had several important limitations. There was probably no uniformity among the patients in terms of door-to-CT times. Also, information on onset-to-CT time was not available on many patients and as a result, a figure representative of all ICH cases could not be stipulated.
These factors may have interfered with estimating the rates of expansion since delayed imaging may have diagnosed ICH at a time when the hematoma had reached maximal expansion.
Nonetheless, this is probably a more accurate representative of real-world stroke care. For expansion analysis, we only included data on patients who had follow-up CT, resulting in a 9.2%
attrition. This may have also lead to preclusion from analyses of a number of patients who had ICH expansion, but without clinical sequelae, thus eliminating the necessity for repeat imaging.
In conclusion, we demonstrated that more than one-third of patients with supratentorial ICH <30 mL in volume die or are severely disabled by 30 days. One in every five supratentorial hematomas of this size category expand. Small thalamic and basal ganglia/internal capsule hemorrhages are a group of supratentorial ICH with similar clinical prognosis. Treatment of smaller-sized hematomas via interventional strategies, particularly hemostatic therapy, should be entertained as a potential focus area for future cerebrovascular research.
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